He is CEO of Oxford PharmaGenesis, an award-winning HealthScience communications consultancy that helps its clients in pharmaceutical and biotechnology companies, patient groups and academia to communicate medical evidence effectively. Chris studied Biochemistry at St Catherine’s College, Oxford, leaving with a DPhil in 1997.
Following a brief stint as a management consultant, he started out as a Medical Writer 20 years ago, taking on more responsibility as his client work grew. As Managing Director and now CEO, he led a management buy-out to secure the ongoing independence of Oxford PharmaGenesis and continue its growth; the company now has over 300 employees in Oxford, London, Cardiff, Cambridge, Basel, Melbourne and Philadelphia. He is Past Chair of the International Society for Medical Publication Professionals, Co-founder of Open Pharma, and a Director of Oxford Health Policy Forum.
Chris believes that accurate and timely communication plays a vital role in evidence-based medicine and publishes and peer reviews original research and systematic reviews in this area and beyond. He is proud of the partnership between Oxford PharmaGenesis and Evidence Aid, a global charity headquartered in Oxford that advocates an evidence-based approach to emergency relief and humanitarian assistance.